Developing: Federal cannabis policy, state licensing, market moves, and product safety updates.
View Latest NewsWhat Today’s Cannabis Policy Shift Means for the Industry
A plain-English breakdown of the latest cannabis regulatory development, who it affects, and what to watch next.
Read the AnalysisCannabis Operators Face New Retail Pressures
Retailers are adjusting strategy as pricing, consumer demand, and compliance demands evolve.
Read More →What Investors Are Watching This Week
Capital access, earnings expectations, and policy uncertainty remain the main market signals.
Read More →Hemp-Derived THC Rules Continue to Shift
Regulators are revisiting intoxicating hemp products as states balance access and safety.
Read More →New Cannabis Research Raises Product Safety Questions
Testing, labeling, and contaminant standards are becoming central to credible cannabis coverage.
Read More →Today’s Cannabis Brief
The most important cannabis industry stories, summarized with context, not copied.
Federal reform debate adds new timing questions
Lawmakers and agencies continue to shape the next phase of federal cannabis policy. Operators are watching for changes that could affect taxes, banking, research, and compliance planning.
Why it matters: Federal uncertainty still shapes every major industry decision.
Source context: Official releases, public agency materials, and hearing records.Retail operators adjust to margin pressure
Dispensaries are reassessing pricing, staffing, and merchandising as competition increases. Better operational discipline is becoming a survival advantage in mature markets.
Why it matters: Margin pressure affects hiring, expansion, and investor confidence.
Source context: Company statements, state data, and operator interviews.Investors look for policy and earnings signals
Public cannabis companies are being evaluated against revenue quality, debt, cash flow, and regulatory catalysts. The market remains sensitive to policy headlines and financing conditions.
Why it matters: Investors need context, not hype.
Source context: Earnings reports, SEC filings, and analyst materials.States review intoxicating hemp product rules
Lawmakers are debating age limits, testing requirements, retail access, and product definitions. The outcome could reshape the hemp-derived THC market.
Why it matters: The hemp and marijuana regulatory divide is narrowing.
Source context: State legislation and agency statements.Product safety scrutiny grows around testing
Researchers and regulators are examining testing consistency, contaminants, and consumer-facing label accuracy. The next phase of industry maturity may depend on stronger product standards.
Why it matters: Safety and transparency are central to consumer trust.
Source context: Agency documents and research publications.Policy & Legal Watch
Federal reform, state cannabis laws, licensing, enforcement, and regulatory updates.
Federal Cannabis Reform
Track bills, agency action, tax questions, and implementation timelines.
Follow federal coverage →State Cannabis Laws
Legalization, licensing, enforcement, taxes, and retail rules by state.
Open the state tracker →Cannabis Rescheduling News
Follow rescheduling developments, agency responses, and industry impact.
Read rescheduling updates →Legal coverage is for news and general information only and is not legal advice.
Business & Markets
Cannabis companies, dispensaries, funding, earnings, M&A, layoffs, and investor news.
Cannabis Business News
Operators, retailers, brands, finance, M&A, and strategy analysis.
Company coverage →Cannabis Markets & Investing
Public companies, earnings, funding, capital access, and investor signals.
Market coverage →Markets and investing coverage is for news and analysis only and is not investment advice.
Hemp, CBD & Cannabinoids
Hemp regulation, CBD policy, intoxicating hemp products, THC beverages, and emerging cannabinoids.
Hemp Regulation News
Farm bill language, state restrictions, and compliance developments.
Read more →CBD Regulation News
Policy, labeling, FDA issues, and category growth.
Read more →Delta-8 & Hemp-Derived THC
State restrictions, testing expectations, and product access.
Read more →THC Beverage News
Retail channels, regulation, and brand strategy.
Read more →Science & Health
Cannabis research, public health, product safety, medical cannabis studies, and cannabinoid science.
Medical Cannabis Research
Studies, outcomes, limitations, and clinical context.
Read more →Cannabis Product Safety
Testing, labeling, contamination, and consumer protection.
Read more →Cannabinoid Science
Cannabinoids, mechanisms, emerging compounds, and research quality.
Read more →Health and science articles should cite primary sources, official agencies, or peer-reviewed research where available. Medical content is reviewed when appropriate.
State Cannabis Tracker
Follow legalization, licensing, tax, retail, and enforcement updates by state.
Company Watch
Track cannabis companies, earnings, executive moves, mergers, acquisitions, closures, and lawsuits.
Public Cannabis Companies
Public operators, filings, and market-facing updates.
Read more →Cannabis M&A
Mergers, acquisitions, consolidation, and asset sales.
Read more →Cannabis Earnings
Quarterly results, revenue trends, and margin signals.
Read more →Cannabis Executive Moves
Leadership changes, board appointments, and management updates.
Read more →Guides & Explainers
Plain-English explainers for cannabis industry readers.
Events & Culture
Cannabis conferences, trade shows, media, culture, advocacy, and community events.
Cannabis Events
Conferences, trade shows, policy forums, and business gatherings.
Read more →Cannabis Culture News
Media, public perception, advocacy, and community trends.
Read more →Cannabis Opinion
Guest columns, analysis, and carefully labeled viewpoints.
Read more →Built for transparent cannabis journalism.
Clear editorial policies, corrections, author information, and contact paths support accountability.
Editorial Standards
How we source, verify, update, and correct stories.
Read more →Corrections Policy
Report an error or request a correction.
Read more →Author Bios
Meet the writers, editors, reviewers, and contributors.
Read more →Contact the Newsroom
Send tips, press releases, corrections, and partnership inquiries.
Read more →